Company Overview | Bioliberty

In 2020, one of our co-founders witnessed firsthand the life-changing impact of losing independence when a close family member was diagnosed with a neurological condition. Watching a loved one struggle with even the simplest daily tasks sparked a powerful question: What if we could give that independence back?

‍That question became the driving force behind Bioliberty. Inspired by a shared vision, Rowan, Ross, Shéa, and Conan combined their engineering expertise and passion for innovation to create a solution which helps individuals work towards greater physical function, independence and quality of life.

Today's focus

Our focus is upper-extremity rehabilitation, combining gamified exercise experiences with innovative soft-robotic assistance that extends the skilled treatment provided by therapists in post-acute care facilities.

Our future vision

Our vision is to support patients throughout their rehabilitation journey, across care settings and into the home. By connecting rehabilitation over time, we can provide richer longitudinal functional data to inform clinical decisions and help patients achieve better outcomes.

Edinburgh, Scotland, is home to our UK headquarters and product development activities. We are proud to build our technology in a country renowned for engineering, scientific discovery, and ambitious ideas.

Boston serves as our US headquarters and a gateway to one of the world’s leading healthcare ecosystems. From here, we work closely with clinicians and research partners to validate our solutions, deepen our understanding of patient needs, and expand access to our technology across the US.

Rowan Armstrong, MEng, RAEng

Chief Executive Officer

After completing a master’s degree in Electrical and Electronic Engineering at the University of Edinburgh, Rowan worked as a Machine Learning Engineer at Spacelabs Healthcare before joining Siemens Healthineers in London. At Siemens, Rowan worked in sales and marketing within Ultrasound, CT, and MRI divisions, before joining the healthcare consulting team. Rowan supported the improvement of clinical processes in various hospitals throughout the pandemic, which involved the implementation of telehealth systems. ‍

Since co-founding Bioliberty in 2020, Rowan has become a Royal Academy of Engineering Fellow, attracted the highest calibre investors in the US and Scotland, and helped form partnerships with some of the largest healthcare providers in the US.

Ross O’Hanlon, MEng

Chief Technology Officer

Ross holds a master’s degree in Electrical and Electronic Engineering with Management from the University of Edinburgh, where he built a strong foundation in robotics, automation, and systems design. He began his career in technology transfer with the GRID Innovation Team at Heriot-Watt University before moving to Edinburgh Innovations. There, he played a key role in commercializing academic research, assisting spin-outs in securing significant investment and contributing to multiple successful exits.

At Bioliberty, Ross leads the technical vision and product development strategy. He oversees the design and engineering of Bioliberty’s therapy technologies, ensuring that every solution is both clinically relevant and scalable.

Conan Bradley, MEng

Chief Commercial Officer

Conan graduated at the top of his class in Product Design Engineering from Queen’s University Belfast, where he developed a strong foundation in innovation and product development. Early in his career, he played a pivotal role in transforming Bloc Blinds, a consumer-focused company, into a medical device manufacturer at the height of the pandemic. This led to the formation of Bloc Medical and the securing of strategic NHS contracts.

Following this, Conan co-founded Bioliberty, where he now leads commercial strategy. His work focuses on scaling Bioliberty’s presence in global healthcare markets to deliver transformative rehabilitation technology to those who need it most. Under his leadership, the company has already established partnerships with some of the most respected rehabilitation providers in the United States.

Shéa Quinn, MEng

Chief Operating Officer

Shéa completed a masters degree in Mechanical Engineering at Queen’s University Belfast. After graduating, Shéa gained industry experience before returning to academia as a PhD researcher, focusing on AI and smart manufacturing. Shéa transitioned into the start-up world, joining Axial 3D, a medical technology company specializing in patient-specific models for pre-operative planning. It was here that Shea developed a passion for entrepreneurship, which ultimately led him to co-found Bioliberty.

As Chief Operating Officer, Shéa is responsible for the day-to-day operations of the business. His role spans across people, operations, product, and finance, ensuring that the company is well-positioned to achieve its ambitious goals.